Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure-activity relationships and discovery strategies to mitigate drug-drug interaction risks.

Article Details

Citation

Orr ST, Ripp SL, Ballard TE, Henderson JL, Scott DO, Obach RS, Sun H, Kalgutkar AS

Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure-activity relationships and discovery strategies to mitigate drug-drug interaction risks.

J Med Chem. 2012 Jun 14;55(11):4896-933. doi: 10.1021/jm300065h. Epub 2012 Mar 27.

PubMed ID
22409598 [ View in PubMed
]
Abstract

Not Available

DrugBank Data that Cites this Article

Binding Properties
DrugTargetPropertyMeasurementpHTemperature (°C)
AmprenavirCytochrome P450 3A4Ki (nM)370N/AN/ADetails
ClopidogrelCytochrome P450 2B6Ki (nM)500N/AN/ADetails
ClopidogrelCytochrome P450 2C19Ki (nM)14300N/AN/ADetails
DasatinibCytochrome P450 3A4Ki (nM)6300N/AN/ADetails
DiltiazemCytochrome P450 3A4Ki (nM)100N/AN/ADetails
ErlotinibCytochrome P450 3A4Ki (nM)6300N/AN/ADetails
GemfibrozilCytochrome P450 2C9IC 50 (nM)9600N/AN/ADetails
ImatinibCytochrome P450 3A4Ki (nM)14300N/AN/ADetails
LapatinibCytochrome P450 3A4Ki (nM)1700N/AN/ADetails
LopinavirCytochrome P450 3A4Ki (nM)1000N/AN/ADetails
MibefradilCytochrome P450 3A4IC 50 (nM)300N/AN/ADetails
MibefradilCytochrome P450 3A4Ki (nM)2300N/AN/ADetails
NefazodoneCytochrome P450 3A4IC 50 (nM)15N/AN/ADetails
NefazodoneCytochrome P450 3A4IC 50 (nM)1500N/AN/ADetails
NefazodoneCytochrome P450 3A4Ki (nM)1000N/AN/ADetails
RaloxifeneCytochrome P450 3A4Ki (nM)9900N/AN/ADetails
RitonavirCytochrome P450 3A4Ki (nM)170N/AN/ADetails
SaquinavirCytochrome P450 3A4Ki (nM)650N/AN/ADetails
TiclopidineCytochrome P450 2C19Ki (nM)3300N/AN/ADetails